Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06956326) titled 'Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation' on May 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Lars Hvid
Condition:
Multiple Sclerosis
Intervention:
Behavioral: Intensive rehab
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: May 1, 2025
Target Sample Size: 64
Countries of Recruitment:
Denmark
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06956326
Publishe...